Skip to main content
Top
Published in: Pituitary 3/2008

01-09-2008 | Case Report

Metastatic pancreatic neuroendocrine tumor presenting as a pituitary space occupying lesion: a case report

Authors: Chamutal Gur, Gadi Lalazar, Asher Salmon, Victoria Dubiner, David J. Gross

Published in: Pituitary | Issue 3/2008

Login to get access

Abstract

Neuroendocrine tumor metastases to the pituitary gland are very rare. There are few case reports of carcinoid tumor metastases to the pituitary, but no cases of pancreatic neuroendocrine pituitary metastases have been reported. In this report we present a 55-year-old female with a sellar mass, ophthalmoplegia and headaches initially thought to represent an invasive null cell pituitary adenoma. However a histological (trans-sphenoidal and liver biopsies) and systemic investigation proved it to be a metastasis of an undiagnosed pancreatic neuroendocrine tumor. Our patient was unique in respect to the location of the metastasis and the uncharacteristically high proliferative index of her tumor. She received conventional therapy consisting of Sandostatin, chemotherapy and radiotherapy as well as labeled somatostatin following an avid uptake on octreotide scanning. Despite a radiological improvement the patient suffered progressive clinical deterioration and died.
Literature
1.
go back to reference Rindi G, Villanacci V, Ubiali A, Scarpa A (2001) Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis. Expert Rev Mol Diagn 1:323–333PubMedCrossRef Rindi G, Villanacci V, Ubiali A, Scarpa A (2001) Endocrine tumors of the digestive tract and pancreas: histogenesis, diagnosis and molecular basis. Expert Rev Mol Diagn 1:323–333PubMedCrossRef
2.
go back to reference Kaltsas GA, Besser GM, Grossman AB (2004) The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 25(3):458–511 (Review)PubMedCrossRef Kaltsas GA, Besser GM, Grossman AB (2004) The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev 25(3):458–511 (Review)PubMedCrossRef
3.
go back to reference Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R (2001) Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 12(Suppl 2):S95–S99PubMedCrossRef Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R (2001) Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 12(Suppl 2):S95–S99PubMedCrossRef
4.
go back to reference Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol A-M, Nilsson O, Perren A, Scarpa A, Scoazee J-Y, Wiedenmann B, all other Frascati consensus conference participants (2006) TNM staging of forefut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449(4):395–401 (Epub 2006 Sep 12)PubMedCrossRef Rindi G, Kloppel G, Alhman H, Caplin M, Couvelard A, de Herder WW, Erikssson B, Falchetti A, Falconi M, Komminoth P, Korner M, Lopes JM, McNicol A-M, Nilsson O, Perren A, Scarpa A, Scoazee J-Y, Wiedenmann B, all other Frascati consensus conference participants (2006) TNM staging of forefut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449(4):395–401 (Epub 2006 Sep 12)PubMedCrossRef
5.
go back to reference Patchell RA, Posner JB (1986) Neurologic complications of carcinoid. Neurology 36(6):745–749PubMed Patchell RA, Posner JB (1986) Neurologic complications of carcinoid. Neurology 36(6):745–749PubMed
6.
go back to reference Shimon I, Hadani M, Nass D, Zwas ST (2004) Malignant bronchial carcinoid tumor metastatic to the pituitary in a thyroid carcinoma patient: successful treatment with surgery, radiotherapy and somatostatin analog. Pituitary 7(1):51–57PubMedCrossRef Shimon I, Hadani M, Nass D, Zwas ST (2004) Malignant bronchial carcinoid tumor metastatic to the pituitary in a thyroid carcinoma patient: successful treatment with surgery, radiotherapy and somatostatin analog. Pituitary 7(1):51–57PubMedCrossRef
7.
go back to reference Rossi ML, Bevan JS, Fleming KA, Cruz-Sanchez F (1988) Pituitary metastasis from malignant bronchial carcinoid. Tumori 74(1):101–105PubMed Rossi ML, Bevan JS, Fleming KA, Cruz-Sanchez F (1988) Pituitary metastasis from malignant bronchial carcinoid. Tumori 74(1):101–105PubMed
8.
go back to reference Huang MC, Lee LS, Ho DM, Cheng H, Chung WY, Huang CI, Hsiao CY, Pan DH (2001) A metastatic pituitary carcinoid tumor successfully treated with gamma knife radiosurgery. Zhonghua Yi Xue Za Zhi (Taipei) 64(7):414–418 Huang MC, Lee LS, Ho DM, Cheng H, Chung WY, Huang CI, Hsiao CY, Pan DH (2001) A metastatic pituitary carcinoid tumor successfully treated with gamma knife radiosurgery. Zhonghua Yi Xue Za Zhi (Taipei) 64(7):414–418
9.
go back to reference Abe T, Matsumoto K, Iida M, Hayashi M, Sanno N, Osamura RY (1997) Malignant carcinoid tumor of the anterior mediastinum metastasis to a prolactin-secreting pituitary adenoma: a case report. Surg Neurol 48(4):389–394PubMedCrossRef Abe T, Matsumoto K, Iida M, Hayashi M, Sanno N, Osamura RY (1997) Malignant carcinoid tumor of the anterior mediastinum metastasis to a prolactin-secreting pituitary adenoma: a case report. Surg Neurol 48(4):389–394PubMedCrossRef
10.
11.
go back to reference Max MB, Deck MDF, Rottenberg DA (1981) Pituitary metastases: incidence in cancer patients and clinical differentiaion from pituitary adenoma. Neurology 31:998–1002PubMed Max MB, Deck MDF, Rottenberg DA (1981) Pituitary metastases: incidence in cancer patients and clinical differentiaion from pituitary adenoma. Neurology 31:998–1002PubMed
12.
go back to reference Komninos J, Vlassopoulou V,Protopapa D, Korfias S, Kontogeorgos G, Sakas DE, Thalassinos NC (2004) Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 89(2):574–580PubMedCrossRef Komninos J, Vlassopoulou V,Protopapa D, Korfias S, Kontogeorgos G, Sakas DE, Thalassinos NC (2004) Tumors metastatic to the pituitary gland: case report and literature review. J Clin Endocrinol Metab 89(2):574–580PubMedCrossRef
13.
go back to reference Fassett DR, Couldwell WT (2004) Metastases to the pituitary gland. Neurosurg Focus 16(4):E8PubMed Fassett DR, Couldwell WT (2004) Metastases to the pituitary gland. Neurosurg Focus 16(4):E8PubMed
15.
go back to reference Zager EL, Hedley-Whyte ET (1987) Metastasis within a pituitary adenoma presenting with bilateral abducens palsies: case report and review of the literature. Neurosurgery 21:383–386PubMedCrossRef Zager EL, Hedley-Whyte ET (1987) Metastasis within a pituitary adenoma presenting with bilateral abducens palsies: case report and review of the literature. Neurosurgery 21:383–386PubMedCrossRef
16.
go back to reference Kulke M (2005) Advances in the treatment of neuroendocrine tumors. Curr Treat Options Oncol 6(5):397–409 (Review)PubMedCrossRef Kulke M (2005) Advances in the treatment of neuroendocrine tumors. Curr Treat Options Oncol 6(5):397–409 (Review)PubMedCrossRef
17.
go back to reference Arnold R (2005) Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol 19(4):491–505 (Review)PubMedCrossRef Arnold R (2005) Endocrine tumours of the gastrointestinal tract. Introduction: definition, historical aspects, classification, staging, prognosis and therapeutic options. Best Pract Res Clin Gastroenterol 19(4):491–505 (Review)PubMedCrossRef
18.
go back to reference Delaunoit T, Rubin J, Neczyporenko F, Erlichman C, Hobday TJ (2005) Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors. Mayo Clin Proc 80(4):502–506 (Review)PubMedCrossRef Delaunoit T, Rubin J, Neczyporenko F, Erlichman C, Hobday TJ (2005) Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumors. Mayo Clin Proc 80(4):502–506 (Review)PubMedCrossRef
19.
go back to reference Imtiaz KE, Monteith P, Khaleeli A (2000) Complete histological regression of metastatic carcinoid tumour after treatment with octreotide. Clin Endocrinol (Oxf) 53:755CrossRef Imtiaz KE, Monteith P, Khaleeli A (2000) Complete histological regression of metastatic carcinoid tumour after treatment with octreotide. Clin Endocrinol (Oxf) 53:755CrossRef
20.
go back to reference Kouvaraki MA, Solorzano CC, Shapiro SE, Yao JC, Perrier ND, Lee JE, Evans DB (2005) Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 89(3):170–185 (Review)PubMedCrossRef Kouvaraki MA, Solorzano CC, Shapiro SE, Yao JC, Perrier ND, Lee JE, Evans DB (2005) Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol 89(3):170–185 (Review)PubMedCrossRef
21.
go back to reference Delauniot T, Ducreux M, Boige V, Dromain C, Sabourin JC, Duvillard P, Schlumberger M, De Baere T, Rougier P, Ruffie P, Elias D, Lasser P, Baudin E (2004) The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? Eur J Cancer 40(4):515–520CrossRef Delauniot T, Ducreux M, Boige V, Dromain C, Sabourin JC, Duvillard P, Schlumberger M, De Baere T, Rougier P, Ruffie P, Elias D, Lasser P, Baudin E (2004) The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? Eur J Cancer 40(4):515–520CrossRef
22.
go back to reference Teunissen JJ, Kwekkeboom DJ, de Jong M, Esser JP, Valkema R, Krenning EP (2005) Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy. Best Pract Res Clin Gastroenterol 19(4):595–616 (Review)PubMedCrossRef Teunissen JJ, Kwekkeboom DJ, de Jong M, Esser JP, Valkema R, Krenning EP (2005) Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy. Best Pract Res Clin Gastroenterol 19(4):595–616 (Review)PubMedCrossRef
23.
go back to reference Kaltsas G, Rockall A, Papadogias D, Reznek R, Grossman AB (2004) Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 151(1):15–27 (Review)PubMedCrossRef Kaltsas G, Rockall A, Papadogias D, Reznek R, Grossman AB (2004) Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours. Eur J Endocrinol 151(1):15–27 (Review)PubMedCrossRef
Metadata
Title
Metastatic pancreatic neuroendocrine tumor presenting as a pituitary space occupying lesion: a case report
Authors
Chamutal Gur
Gadi Lalazar
Asher Salmon
Victoria Dubiner
David J. Gross
Publication date
01-09-2008
Publisher
Springer US
Published in
Pituitary / Issue 3/2008
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-007-0053-7

Other articles of this Issue 3/2008

Pituitary 3/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.